In a 15 October 2018 statement, the National Coffee Association in the US said it welcomed the postponement of the ‘coffee and cancer’ trial that was due to commence that day.
The California Court of Appeal ruled on 12 October 2018 that the highly controversial trial would not go ahead as scheduled.
“The court’s order is an important step forward, towards common sense and resolving this outrageous lawsuit that has dragged through the courts since 2011,” said National Coffee Association (NCA) President and CEO, Bill Murray.
“This lawsuit not only seeks to mislead consumers by placing a label on coffee falsely linking coffee consumption to cancer, but to extract millions of dollars from coffee companies for their failure to provide such a false warning.”
More than 500 published, high quality peer-reviewed human studies, covering several million people, have concluded that no connection exists between coffee and cancer, findings which have been confirmed and endorsed by the World Health Organization’s International Agency for Research on Cancer.
“Coffee does not increase the risk of cancer. Independent research shows that coffee drinkers have a lower incidence than noncoffee drinkers of several of the most common cancer types, including cancer of the liver, prostate, breast, and colon,” said Mr Murray.
As previously highlighted by C&CI, California’s own state regulator (the OEHHA) announced in June a draft rule agreeing with scientific evidence that “drinking coffee does not pose a significant cancer risk” and clarifying that “Prop 65 cancer warnings” are not required on coffee. The rule is set to be finalized as early as November.
“The court’s decision postponing the scheduled trial on this case is one more victory for science, common sense and coffee drinkers everywhere,” said Mr Murray.